A deep dive into the world of rare diseases, plus insight from Teckro’s Brendan Buckley on the adoption of technology to transform rare disease clinical trials.
Teckro CEO Gary Hughes on operating for the greater good.
Dr. Deborah Zajchowski, scientific director for the Clearity Foundation.
Nick Bruggeman, Founder & VP of Business Development, CCT Research.
Frances Reid, Program Director for the World Ovarian Cancer Coalition.
Malia Lewin on charting the best possible route to oncology trial success.
Gary Hughes, Teckro CEO and Co-founder
Fewer protocol deviations. Better trial data quality. Faster, safer, more efficient clinical trials allowing new drugs and treatments to come quickly to market. Our sponsors continue to add more clinical trials on Teckro. In the end, lives are saved, pain and suffering are eased, and quality of life is improved.
Every clinical trial starts with a question. At Teckro, our question was: “How can clinical trials be more simple, accessible, and transparent?” In today’s digital world, reliable answers are just a tap away. Digital connections allow us to stay engaged with the people in our lives, whether professional or personal. Why shouldn’t the same be true for clinical trials?